Atherosclerosis is considered a frequent cause of cardiovascular diseases and strokes. Despite medical progress, case numbers are constantly rising. Targeted new therapeutic approaches are therefore more important than ever.
Nov 2, 2023
0
19
Researchers have developed an inhalable powder that could protect lungs and airways from viral invasion by reinforcing the body's own mucosal layer. The powder, called Spherical Hydrogel Inhalation for Enhanced Lung Defense, ...
Feb 9, 2023
0
110
RIKEN neuroscientists have discovered a surprising mechanism for how neuronal activity in mice is dynamically tuned—with signaling at some synapses increasing, while other synapses go quiet—so as to promote the process ...
Feb 22, 2022
0
106
A new study by researchers at Yale Cancer Center shows inhibition of the CECR2 gene prevents triple-negative breast cancer from advancing or metastasizing. The discovery is an early step in finding new therapeutics for triple-negative ...
Feb 3, 2022
0
137
An international team of scientists have created a three-dimensional (3-D) pancreatic cancer tumour model in the laboratory, combining a bioengineered matrix and patient-derived cells that could be used to develop and test ...
Sep 24, 2021
0
58
There could be an intervention on the horizon to help prevent heart damage caused by the common chemotherapy drug doxorubicin, new research suggests.
Jan 25, 2021
0
39
Organoids are increasingly being used in biomedical research. These are organ-like structures created in the laboratory that are only a few millimeters in size. Organoids can be used to study life processes and the effect ...
Jan 19, 2021
0
29
A non-hallucinogenic version of the psychedelic drug ibogaine, with potential for treating addiction, depression and other psychiatric disorders, has been developed by researchers at the University of California, Davis. A ...
Dec 9, 2020
0
124
A new study led by researchers at the University of Kentucky Markey Cancer Center and UK Department of Pharmacology and Nutritional Sciences demonstrates the potential benefit of using an anti-leukemic drug nilotinib—most ...
Oct 30, 2020
2
66
Scientists have created a three-dimensional (3-D) tumor model in the laboratory for ovarian cancer that could lead to improved understanding and treatment of the disease.
Oct 2, 2020
0
84
